{
    "root": "31410594-5679-099c-e063-6294a90a8ca5",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Irbesartan",
    "value": "20250326",
    "ingredients": [
        {
            "name": "CALCIUM STEARATE",
            "code": "776XM7047L",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_190296"
        },
        {
            "name": "CARBOXYMETHYLCELLULOSE CALCIUM",
            "code": "UTY7PDF93L",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_85146"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30563"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14158"
        },
        {
            "name": "POVIDONE K30",
            "code": "U725QWY32X",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14478"
        },
        {
            "name": "IRBESARTAN",
            "code": "J0E2756Z7N",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_5959"
        }
    ],
    "indications": {
        "text": "irbesartan tablet angiotensin ii receptor blocker ( arb ) indicated : \u2022 treatment hypertension , lower blood pressure . lowering blood pressure reduces risk fatal nonfatal cardiovascular events , primarily strokes myocardial infarctions . ( 1.1 ) \u2022 treatment diabetic nephropathy hypertensive patients type 2 diabetes , elevated serum creatinine , proteinuria . ( 1.2 )",
        "doid_entities": [
            {
                "text": "hypertension (DOID:10763)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_10763"
            },
            {
                "text": "nephropathy (DOID:557)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_557"
            },
            {
                "text": "type 2 diabetes (DOID:9352)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_9352"
            },
            {
                "text": "diabetes (DOID:9351)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_9351"
            },
            {
                "text": "proteinuria (DOID:576)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_576"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "indication dose hypertension ( 2.2 ) 150 300 mg daily diabetic nephropathy ( 2.3 ) 300 mg daily",
        "doid_entities": [
            {
                "text": "hypertension (DOID:10763)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_10763"
            },
            {
                "text": "nephropathy (DOID:557)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_557"
            }
        ],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "irbesartan tablets usp , 75 mg white white , capsule shaped , biconvex tablets , debossed '158 ' one side ' h ' side . supplied ndc : 70518-2685-00 ndc : 70518-2685-01 packaging : 90 1 bottle plastic packaging : 90 1 bottle plastic store 20\u00b0 25\u00b0c ( 68\u00b0 77\u00b0f ) [ usp controlled room temperature ] repackaged distributed : remedy repack , inc. 625 kolter dr. suite # 4 indiana , pa 1-724-465-8762",
    "adverseReactions": "irbesartan tablets contraindicated patients hypersensitive component product . co-administrate aliskiren irbesartan tablets patients diabetes .",
    "indications_original": "Irbesartan tablet is an angiotensin II receptor blocker (ARB) indicated for: \u2022\u00a0Treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. ( 1.1 ) \u2022\u00a0Treatment of diabetic nephropathy in hypertensive patients with type 2 diabetes, an elevated serum creatinine, and proteinuria. ( 1.2 )",
    "contraindications_original": "Indication Dose Hypertension ( 2.2 ) 150 to 300 mg once daily Diabetic Nephropathy ( 2.3 ) 300 mg once daily",
    "warningsAndPrecautions_original": "Irbesartan Tablets USP, 75 mg are white to off white, capsule shaped, biconvex tablets, debossed with '158' on one side and 'H'\u00a0on the other side. They are supplied in\n                  NDC: 70518-2685-00\n                  NDC: 70518-2685-01\n                  PACKAGING: 90 in 1 BOTTLE PLASTIC\n                  PACKAGING: 90 in 1 BOTTLE PLASTIC\n                  \n                  Store at 20\u00b0 to 25\u00b0C (68\u00b0 to 77\u00b0F) [see USP Controlled Room Temperature]\n                  \n                  Repackaged and Distributed By:\n                  Remedy Repack, Inc.\n                  625 Kolter Dr. Suite #4 Indiana, PA 1-724-465-8762",
    "adverseReactions_original": "Irbesartan tablets are contraindicated in patients who are hypersensitive to any component of this product. \n    Do not co-administrate aliskiren with irbesartan tablets in patients with diabetes.",
    "drug": [
        {
            "name": "Irbesartan",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_5959"
        }
    ]
}